Showing results (31-40 of 80) with videos related to
Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|February 11, 2024
Rational design, synthesis and biological evaluation of novel HIV-1 protease inhibitors containing 2-phenylacetamide derivatives as P2 ligands with potent activity against DRV-Resistant HIV-1 variantsSihan Meng, Yu Gao, Guowei Qiang, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 23, 2013
Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitroYing Liu, Zu-an Zhu, Shang-Nuan Zhang, et al.Cell Death & Disease|October 27, 2017
MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5Yao-Jie Pan, Lu-Lu Wei, Xiao-Jin Wu, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 19, 2018
RETRACTED: GZMB gene silencing confers protection against synovial tissue hyperplasia and articular cartilage tissue injury in rheumatoid arthritis through the MAPK signaling pathwayCui-Xia Bao, Hai-Xia Chen, Xue-Jie Mou, et al.Rejuvenation Research|March 21, 2023
Alginate Oligosaccharides Enhance Autophagy to Rejuvenate H<sub>2</sub>O<sub>2</sub>-Induced Senescent IEC-6 Through the AMPK/mTOR Signaling PathwayXinxiu Zhao, Shixian Zhou, Shunmei Huang, et al.Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi = Zhonghua Laodong Weisheng Zhiyebing Zazhi = Chinese Journal of Industrial Hygiene and Occupational Diseases|February 3, 2016
[Effects of hyperbaric oxygen preconditioning on human stress responses during acute exposure to high altitude]Yangyang Li, Lu Shi, Nanning Wu, et al.Current Pharmaceutical Design|April 20, 2022
LncRNA SBF2-AS1: A Budding Star in Various CancersFangshun Tan, Jinlan Chen, Bei Wang, et al.Current Pharmaceutical Design|March 25, 2022
FER1L4: A Long Non-coding RNA with Multiple Roles in the Occurrence and Development of TumorsJie Mou, Bei Wang, Yuling Liu, et al.Frontiers in Cell and Developmental Biology|July 4, 2025
LncRNA CHRF: molecular mechanisms and therapeutic potentials in cardiovascular diseases, cancers and fibrosisJie Mou, Chuntao Luo, Wen Zhang, et al.Current Pharmaceutical Design|August 30, 2021
The Regulatory Role of Both MBNL1 and MBNL1-AS1 in Several Common CancersQi Zhang, Yinxin Wu, Jinlan Chen, et al.Pageof 8